King Kong of drugs a revenue booster

Sigma Healthcare has reported "above the norm" sales growth driven by weight loss drugs, with the CEO describing them as "a rising tide" that "has lifted all the groups".

Over the past decade Chemist Warehouse has delivered a compound annual growth rate of 11.3 per cent, but for the financial year 2026 it saw like-for-like sales growth of 13.4 per cent. Total group sales grew 15.5 per cent to hit $10.835 billion.

"The ambition and the way we target growth in the organisation is at least aiming for double-digit like-for-like sales growth," Sigma CEO, Vikesh Ramsunder, told a conference call. "And you're seeing the 13 per cent, really, that's been driven by GLP-1s. So that's slightly above the norm."